Preferred Label : Remestemcel-L;

NCIt synonyms : Allogeneic Adult Mesenchymal Stem Cells; Allogeneic Adults MSCs; Allogeneic Expanded Mesenchymal Stem Cells;

NCIt definition : Human mesenchymal stem cells (MSCs) harvested from bone marrow of healthy adult donors and expanded ex vivo, with potential immunosuppressive application. Allogeneic adult MSCs are hypo-immunogenic due to lack of major histocompatibility II (MHC II) molecule expression, and thereby elicit none or minimal immune response upon intravenous infusion. MSCs are pluripotent, and are capable of being recruited to damaged tissue sites and differentiating along specific lineages when stimulated. Infusion of MSCs results in: a) increased production of anti-inflammatory cytokines, such as interleukin-10, prostaglandin E, and hepatocyte growth factor; b) decreased mononuclear phagocyte expression of indoleamine 2,3,-dioxygenase, which catabolizes L-tryptophan into its metabolites, which in turn contribute to inflammation; and c) modulated dendritic cell maturation and disrupted activities of natural killer cells, CD8 and CD4 T cells.;

UNII : H57D26Z9YK;

Drug name : Prochymal;

Molecule name : JR-0301;

Details


Main resources

You can consult :


Summary Basis of Decision (SBD) for Prochymal
Remestemcel-L, Adult Human Mesenchymal Stem Cells (hMSCs) 100 106 hMSCs per 15 mL, cell suspension
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00118
2012
false
Canada
French
English
Remestemcel-L
drug information
Product containing human mesenchymal stem cell (medicinal product)
Human mesenchymal stem cell (substance)
Mesenchymal Stem Cells
drug approval
canada
graft vs host disease
acute disease
child
treatment outcome
drug compounding
infusions, intravenous
drug evaluation
risk assessment

---
Nous contacter.
22/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.